Basic Information
| LncRNA/CircRNA Name | LINC01793 |
| Synonyms | NA |
| Region | GRCh38_2:59217708-59279400 |
| Ensemble | ENSG00000222030 |
| Refseq | NR_110219 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot |
| Sample | gastric cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | LINC01793 was overexpressed in gastric cancer tissues compared to paracancerous tissues. Moreover, LINC01793 overexpression in gastric cancer was closely related to patients with poor prognosis. |
| Pubmed ID | 29978448 |
| Year | 2018 |
| Title | Overexpression of lncRNA LINC01793 Acts as a Potential Predictor for Progression and Poor Prognosis of Gastric Cancer |
External Links
| Links for LINC01793 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |